Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07412704 · ClinicalTrials.gov registry record · Phase 1
A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
A Phase 1 study, sponsored by Bristol-Myers Squibb.
- Not yet
- Registry status
- Phase 1
- Development phase
- 84
- Enrollment target
NCT07412704: Clinical Trial Phase 1 study, sponsored by Bristol-Myers Squibb.
NCT07412704 is a Phase 1 study that has not yet begun recruiting, run by Bristol-Myers Squibb. The registered enrollment target is 84 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (40% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07412704, a Phase 1 study, has not yet begun recruiting, sponsored by Bristol-Myers Squibb.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 84 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and the preliminary evidence of disease-modifying effect of BMS-986528 in participants with refractory, difficult-to-treat rheumatoid arthritis (RA).
Interventions
- DRUG BMS-986528
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2026-05-28 |
| Est. Completion | 2030-09-02 |
| Phase | Phase 1 |
What is known before NCT07412704 opens enrollment
NCT07412704 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (40% higher).
The record links to 0 conditions, and to 1 intervention - of which BMS-986528 is the first listed.
NCT07412704 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07412704 about?
NCT07412704 is a clinical study titled "A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis". The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and the preliminary evidence of disease-modifying effect of BMS-986528 in participants with refractory, difficult-to-treat rheumatoid arthritis (RA).
What is the current status of trial NCT07412704?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 84 participants. The study started on 2026-05-28. Estimated completion is 2030-09-02.
What interventions are being tested in trial NCT07412704?
The interventions under investigation include: BMS-986528 (DRUG).
Who is sponsoring clinical trial NCT07412704?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07412704's enrollment target sits among peer trials
84 659th of 2000 higher than 1,336 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI